MPO and neoplasm: HZ-5 NPs can specifically target neutrophils through MPO-catalyzed aggregation in tumor tissues, ensuring that drugs loaded onto HZ-5 NPs could be concentrated, retained, and released in a sustained manner at the tumor site, thus achieving effective tumor suppression and resistance against neutrophil-mediated lung metastasis.